References
- KiernanDFMielerWFHariprasadSMSpectral-domain optical coherence tomography: a comparison of modern high-resolution retinal imaging systemsAm J Ophthalmol20101491183120103039
- WolfSWolf-SchnurrbuschUSpectral-domain optical coherence tomography use in macular diseases: a reviewOphthalmologica2010224633334020453539
- EisnerALuohSWBreast cancer medications and vision: effects of treatments for early-stage diseaseCurr Eye Res2011361086788521819259
- HagerTHoffmannSSeitzBUnusual symptoms for tamoxifen-associated maculopathyOphthalmologe20101078750752 German20393723
- SrikantiaNMukeshSKrishnaswamyMCrystalline maculopathy: a rare complication of tamoxifen therapyJ Cancer Res Ther20106331331521119261
- ChungHKimDAhnSHEarly detection of tamoxifen-induced maculopathy in patients with low cumulative doses of tamoxifenOphthalmic Surg Lasers Imaging2010915 Epub392010
- TolerSMOxidative stress plays an important role in the pathogenesis of drug-induced retinopathyExp Biol Med (Maywood)2004229760761515229354
- Mauget-FaÿsseMGambrelleJQuaranta-ElMaftouhiMOptical coherence tomography in tamoxifen retinopathyBreast Cancer Res Treat200699111711816541311
- GianniLPanziniILiSInternational Breast Cancer Study Group (IBCSG)Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trialsCancer2006106350551316369994
- GualinoVCohenSYDelyferMNSahelJAGaudricAOptical coherence tomography findings in tamoxifen retinopathyAm J Ophthalmol2005140475775816226541